A Discussion With Experts on the Evolving Therapeutic Landscape in T-Cell Lymphomas: Focus on EZH1/2 Inhibitors

Download these slides from a live expert-led satellite symposium reviewing the latest advances in peripheral T-Cell lymphomas.

Steven M. Horwitz, MD
Program Director Pamela B. Allen, MD Released: June 2, 2022

Download these slides from a live expert-led satellite symposium reviewing the mechanisms of Anti-EZH1 and EZH2 therapies in PTCL.

Steven M. Horwitz, MD
Program Director Pierluigi Porcu, MD Released: June 2, 2022

Download these slides from a live expert-led satellite symposium reviewing the clinical trial efficacy and safety of Anti-EZH1 and EZH2 therapies in PTCL.

Steven M. Horwitz, MD Released: June 3, 2022

In this on-demand webcast from a live symposium, Steven M. Horwitz, MD; Pamela B. Allen, MD; and Pierluigi Porcu, MD discuss the rationale, evidence, and strategies for using EZH1/2 inhibitors in patients with peripheral T-cell lymphomas.

Steven M. Horwitz, MD
Program Director Pamela B. Allen, MD Pierluigi Porcu, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: June 8, 2022 Expired: June 7, 2023